Biochemical and imaging markers in patients with thalassaemia

Area of Science:

• Cardiology
• Genetics
• Biomarker Research

Background:

• Beta-thalassaemia is a genetic disorder with diverse clinical manifestations.
• Heart failure is a significant complication in beta-thalassaemia, arising from multifactorial mechanisms.
• Early detection and management of cardiac complications are vital for improving patient outcomes.

Purpose of the Study:

• To review the current clinical utility of cardiac biomarkers in managing heart disease in beta-thalassaemia patients.
• To explore emerging research on novel biomarkers for early diagnosis, staging, and prognosis.
• To discuss the potential future applications of cardiac biomarkers in beta-thalassaemia management.

Main Methods:

• Literature review of studies on cardiac biomarkers in beta-thalassaemia.
• Analysis of current clinical guidelines and research trends.
• Synthesis of data on diagnostic, prognostic, and staging capabilities of biomarkers.

Main Results:

• Cardiac biomarkers play a key role in the early identification and monitoring of heart disease in beta-thalassaemia.
• Existing biomarkers aid in assessing disease severity and predicting prognosis.
• Ongoing research is identifying new biomarkers with potential for enhanced clinical utility.

Conclusions:

• Cardiac biomarkers are indispensable tools for managing heart disease in beta-thalassaemia.
• Further research promises to expand the role of biomarkers in personalized patient care.
• Optimizing biomarker use can lead to improved early diagnosis and treatment strategies.